Hebenstreit Doris, Csaicsich Dagmar, Hebenstreit Karin, Müller-Sacherer Thomas, Berlakovich Gabriela, Springer Alexander
Department of Urology, Medical University Innsbruck, Austria.
Department of Pediatrics, Medical University Vienna, Austria.
J Pediatr Surg. 2018 Nov;53(11):2256-2260. doi: 10.1016/j.jpedsurg.2018.07.003. Epub 2018 Jul 6.
To determine whether there is a difference in the outcome of renal transplantation (RT) in patients with posterior urethral valves (PUV) and children with non-uropathy related end stage renal disease.
Data were acquired retrospectively. We analyzed possible factors that influence the function of renal allografts and graft survival. Between 1995 and 2016 there were 149 RT. Out of them, there were 27 boys with PUV, who received 29 kidneys. Thirty patients, who received a total of 31 renal grafts due to a non-uropathic (NU) diagnosis, served as control group. Mean follow-up was 7.4 to 10.2 years.
There was no difference in estimated graft survival between patients with PUV and NU patients. Graft failure occurred in 23.1% of PUV patients and 34.5% patients of the NU group. There was no statistically significant disparity in graft function between the two groups. Age at transplantation and donor age were the only factors that had a significant impact on renal function. There was a higher incidence of UTI in the PUV group (96%) than in the NU group (67%). Vesicostomy was the favourable intervention in regards of graft function.
RT in PUV patients is successful with the same outcome as in NU patients. Bladder dysfunction may not have a major impact on graft function and graft survival. It seems that the type of pre-transplant surgical procedures may influence outcome. Therefore, these interventions -if necessary- should be limited to a minimum.
Retrospective Comparative Study LEVEL OF EVIDENCE: Level III.
确定后尿道瓣膜症(PUV)患者与非泌尿系统疾病相关终末期肾病儿童肾移植(RT)的结果是否存在差异。
回顾性收集数据。我们分析了影响同种异体肾移植功能和移植肾存活的可能因素。1995年至2016年间共有149例肾移植。其中,27例患有PUV的男孩接受了29个肾脏。30例因非泌尿系统疾病(NU)诊断接受了总共31个肾移植的患者作为对照组。平均随访时间为7.4至10.2年。
PUV患者与NU患者的估计移植肾存活率无差异。PUV患者中23.1%发生移植肾失败,NU组患者中34.5%发生移植肾失败。两组间移植肾功能无统计学显著差异。移植时年龄和供体年龄是仅对肾功能有显著影响的因素。PUV组尿路感染发生率(96%)高于NU组(67%)。膀胱造瘘术对移植肾功能而言是有利的干预措施。
PUV患者的肾移植是成功的,结果与NU患者相同。膀胱功能障碍可能对移植肾功能和移植肾存活无重大影响。似乎移植前手术程序的类型可能影响结果。因此,如有必要,这些干预措施应限制在最低限度。
回顾性比较研究 证据水平:三级